You just read:

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

News provided by

OBI Pharma, Inc.

Sep 19, 2018, 05:00 ET